PURPOSE: To evaluate the choroidal thickness in patients with ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography (EDI-OCT) and comparing it with normal subjects. METHOD: Eighteen eyes of 9 patients with ocular sarcoidosis (8 women, 1 man, mean age: 59.12 ± 18.49 years) were enrolled in this study. Their subfoveal choroidal thickness was measured using EDI-OCT in the quiescent phase of uveitis, and compared with the age-, sex-, and spherical equivalent-matched normal subjects (6 women, 3 men, mean age: 59.6 ± 14.22 years). RESULTS: The mean subfoveal choroidal thickness was 281.76 ± 88.1 µm in patients with sarcoidosis and 342.32 ± 71.02 µm in controls. Significant differences were found at points between nasal 1500 µm and temporal 1000 µm to the fovea between patients and control group (p = 0.002, at fovea). CONCLUSIONS: Patients with ocular sarcoidosis had thinner choroids in the quiescent phases when compared to normal subjects.
PURPOSE: To evaluate the choroidal thickness in patients with ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography (EDI-OCT) and comparing it with normal subjects. METHOD: Eighteen eyes of 9 patients with ocular sarcoidosis (8 women, 1 man, mean age: 59.12 ± 18.49 years) were enrolled in this study. Their subfoveal choroidal thickness was measured using EDI-OCT in the quiescent phase of uveitis, and compared with the age-, sex-, and spherical equivalent-matched normal subjects (6 women, 3 men, mean age: 59.6 ± 14.22 years). RESULTS: The mean subfoveal choroidal thickness was 281.76 ± 88.1 µm in patients with sarcoidosis and 342.32 ± 71.02 µm in controls. Significant differences were found at points between nasal 1500 µm and temporal 1000 µm to the fovea between patients and control group (p = 0.002, at fovea). CONCLUSIONS:Patients with ocular sarcoidosis had thinner choroids in the quiescent phases when compared to normal subjects.
Authors: Jane S Kim; Jared E Knickelbein; Laurence Jaworski; Padmini Kaushal; Susan Vitale; Robert B Nussenblatt; H Nida Sen Journal: Am J Ophthalmol Date: 2016-01-29 Impact factor: 5.258
Authors: H Mehta; D A Sim; P A Keane; J Zarranz-Ventura; K Gallagher; C A Egan; M Westcott; R W J Lee; A Tufail; C E Pavesio Journal: Eye (Lond) Date: 2015-05-29 Impact factor: 3.775
Authors: Samantha Sze-Yee Lee; Darren John Beales; Fred K Chen; Seyhan Yazar; David Alonso-Caneiro; David A Mackey Journal: Sci Rep Date: 2021-03-17 Impact factor: 4.379
Authors: John A Belperio; Faisal Shaikh; Fereidoun Abtin; Michael C Fishbein; Rajan Saggar; Edmund Tsui; Joseph P Lynch Journal: EClinicalMedicine Date: 2021-06-27